40193 |
Endocrinology & Metabolism |
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Sta... |
ENDOCRINOL METAB 2021 10.3803/EnM.2020.908 |
박병관 |
2021 |
40192 |
Orthopedics |
Patient-Perceived Outcomes After Nonoperative Treatment of Distal Radi... |
ORTHOPEDICS 2021 10.3928/01477447-20201210-04 |
박민종 |
2021 |
40191 |
Oncology; Respiratory System |
Phase I results of S49076 plus gefitinib in patients with EGFR TKI-res... |
LUNG CANCER 2021 10.1016/j.lungcan.2021.03.012 |
박근칠 |
2021 |
40190 |
Oncology |
Olmutinib in T790M-positive non-small cell lung cancer after failure o... |
CANCER 2021 10.1002/cncr.33385 |
박근칠 |
2021 |
40189 |
Medicine, General & Internal |
Induction chemotherapy followed by concurrent chemoradiotherapy versus... |
KOREAN J INTERN MED 2021 10.3904/kjim.2019.161 |
박근칠 |
2021 |
40188 |
Oncology |
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease S... |
J CLIN ONCOL 2021 10.1200/JCO.20.02212 |
박근칠 |
2021 |
40187 |
Oncology; Respiratory System |
Impact of subsequent immune checkpoint inhibitor treatment on overall ... |
LUNG CANCER 2021 10.1016/j.lungcan.2021.01.026 |
박근칠 |
2021 |
40186 |
Immunology |
Tumor infiltrated immune cell types support distinct immune checkpoint... |
EUR J IMMUNOL 2021 10.1002/eji.202048966 |
박근칠 |
2021 |
40185 |
Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy |
The NHance Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Incre... |
BIOMEDICINES 2021 10.3390/biomedicines9060665 |
박근칠 |
2021 |
40184 |
Oncology |
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination... |
CLIN CANCER RES 2021 10.1158/1078-0432.CCR-20-1690 |
박근칠 |
2021 |